{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T15:44:02Z","timestamp":1792511042265,"version":"4.5.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T00:00:00Z","timestamp":1784851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T00:00:00Z","timestamp":1792454400000},"content-version":"vor","delay-in-days":88,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Natural Science Foundation of Gansu Province","award":["26JRRA351"],"award-info":[{"award-number":["26JRRA351"]}]},{"name":"Gansu Provincial Department of Education: 2026 Graduate Innovation Star Project","award":["2026CXZX-111"],"award-info":[{"award-number":["2026CXZX-111"]}]},{"name":"Lanzhou Talent Innovation and Entrepreneurship Program","award":["2023-RC-29"],"award-info":[{"award-number":["2023-RC-29"]}]},{"name":"the Foundation of The First Hospital of Lanzhou University, China","award":["ZX-62000002-2025-555"],"award-info":[{"award-number":["ZX-62000002-2025-555"]}]},{"name":"Open Research Fund of the National Key Laboratory of Neural and Tumor Drug Development","award":["SKLSIM-20251451"],"award-info":[{"award-number":["SKLSIM-20251451"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-026-16456-7","type":"journal-article","created":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T09:25:02Z","timestamp":1784885102000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Pan-cancer analysis identifies KPNA7 as a prognostic and immune-related biomarker with functional relevance in gastric cancer"],"prefix":"10.1186","volume":"26","author":[{"given":"Xia","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ailin","family":"Yue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiyun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiming","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,24]]},"reference":[{"issue":"8","key":"16456_CR1","doi-asserted-by":"publisher","first-page":"2254","DOI":"10.1016\/j.cell.2025.12.049","volume":"189","author":"D Hanahan","year":"2026","unstructured":"Hanahan D. Hallmarks of cancer-Then and now, and beyond. Cell. 2026;189(8):2254\u201377.","journal-title":"Cell"},{"issue":"6","key":"16456_CR2","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1016\/j.ccell.2024.05.004","volume":"42","author":"CS McGinnis","year":"2024","unstructured":"McGinnis CS, Miao Z, Superville D, Yao W, Goga A, Reticker-Flynn NE, Winkler J, Satpathy AT. The temporal progression of lung immune remodeling during breast cancer metastasis. Cancer Cell. 2024;42(6):1018\u2013e10311016.","journal-title":"Cancer Cell"},{"issue":"1","key":"16456_CR3","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s13045-024-01634-6","volume":"18","author":"A Glaviano","year":"2025","unstructured":"Glaviano A, Lau HS, Carter LM, Lee EHC, Lam HY, Okina E, Tan DJJ, Tan W, Ang HL, Carbone D, et al. Harnessing the tumor microenvironment: targeted cancer therapies through modulation of epithelial-mesenchymal transition. J Hematol Oncol. 2025;18(1):6.","journal-title":"J Hematol Oncol"},{"key":"16456_CR4","doi-asserted-by":"publisher","first-page":"1563858","DOI":"10.3389\/fimmu.2025.1563858","volume":"16","author":"Y Wang","year":"2025","unstructured":"Wang Y, Zhou H, Ju S, Dong X, Zheng C. The solid tumor microenvironment and related targeting strategies: a concise review. Front Immunol. 2025;16:1563858.","journal-title":"Front Immunol"},{"issue":"3","key":"16456_CR5","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.ccell.2023.12.021","volume":"42","author":"L Cords","year":"2024","unstructured":"Cords L, Engler S, Haberecker M, R\u00fcschoff JH, Moch H, de Souza N, Bodenmiller B. Cancer-associated fibroblast phenotypes are associated with patient outcome in non-small cell lung cancer. Cancer Cell. 2024;42(3):396\u2013e412395.","journal-title":"Cancer Cell"},{"issue":"1","key":"16456_CR6","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1038\/s41392-025-02280-1","volume":"10","author":"M Tufail","year":"2025","unstructured":"Tufail M, Jiang CH, Li N. Immune evasion in cancer: mechanisms and cutting-edge therapeutic approaches. Signal Transduct Target therapy. 2025;10(1):227.","journal-title":"Signal Transduct Target therapy"},{"key":"16456_CR7","doi-asserted-by":"publisher","first-page":"1597202","DOI":"10.3389\/fimmu.2025.1597202","volume":"16","author":"X Zhao","year":"2025","unstructured":"Zhao X, Zhu Y, He Y, Gu W, Zhou Q, Jin B, Chen S, Lin H. Unraveling the immune evasion mechanisms in the tumor microenvironment of head and neck squamous cell carcinoma. Front Immunol. 2025;16:1597202.","journal-title":"Front Immunol"},{"issue":"10","key":"16456_CR8","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1038\/s41571-024-00932-9","volume":"21","author":"J Budczies","year":"2024","unstructured":"Budczies J, Kazdal D, Menzel M, Beck S, Kluck K, Altb\u00fcrger C, Schwab C, Allg\u00e4uer M, Ahadova A, Kloor M, et al. Tumour mutational burden: clinical utility, challenges and emerging improvements. Nat reviews Clin Oncol. 2024;21(10):725\u201342.","journal-title":"Nat reviews Clin Oncol"},{"issue":"8","key":"16456_CR9","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1038\/s43018-024-00772-7","volume":"5","author":"TG Chang","year":"2024","unstructured":"Chang TG, Cao Y, Sfreddo HJ, Dhruba SR, Lee SH, Valero C, Yoo SK, Chowell D, Morris LGT, Ruppin E. LORIS robustly predicts patient outcomes with immune checkpoint blockade therapy using common clinical, pathologic and genomic features. Nat cancer. 2024;5(8):1158\u201375.","journal-title":"Nat cancer"},{"issue":"1","key":"16456_CR10","doi-asserted-by":"publisher","first-page":"bbae648","DOI":"10.1093\/bib\/bbae648","volume":"26","author":"Y Wang","year":"2024","unstructured":"Wang Y, Guan Y, Lai X, Liu Y, Chang Z, Wang X, Wang Q, Liu J, Zhao J, Yang S, et al. THOR: a TMB heterogeneity-adaptive optimization model predicts immunotherapy response using clonal genomic features in group-structured data. Brief Bioinform. 2024;26(1):bbae648.","journal-title":"Brief Bioinform"},{"issue":"4","key":"16456_CR11","doi-asserted-by":"publisher","first-page":"108343","DOI":"10.1016\/j.jbc.2025.108343","volume":"301","author":"K Mizuno","year":"2025","unstructured":"Mizuno K, Sugahara M, Kutomi O, Kato R, Itoh T, Fujita S, Yamada M. Direct observation of importin \u03b1 family member KPNA1 in axonal transport with or without a schizophrenia-related mutation. J Biol Chem. 2025;301(4):108343.","journal-title":"J Biol Chem"},{"issue":"12","key":"16456_CR12","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.1038\/sj.onc.1202350","volume":"18","author":"SH Liang","year":"1999","unstructured":"Liang SH, Clarke MF. The nuclear import of p53 is determined by the presence of a basic domain and its relative position to the nuclear localization signal. Oncogene. 1999;18(12):2163\u20136.","journal-title":"Oncogene"},{"issue":"7","key":"16456_CR13","doi-asserted-by":"publisher","first-page":"e70731","DOI":"10.1002\/cam4.70731","volume":"14","author":"Y Hu","year":"2025","unstructured":"Hu Y, Zhou J, Ling X, Zhao K, Huang P, Gao M, Li X, Sun M, Zou Y, Feng G. KPNA5 Suppresses Malignant Progression of Ovarian Cancer Through Importing the PTPN4 Into the Nucleus. Cancer Med. 2025;14(7):e70731.","journal-title":"Cancer Med"},{"issue":"1","key":"16456_CR14","doi-asserted-by":"publisher","first-page":"17140","DOI":"10.1038\/s41598-024-66678-7","volume":"14","author":"X Chen","year":"2024","unstructured":"Chen X, Wei H, Yue A, Zhang H, Zheng Y, Sun W, Zhou Y, Wang Y. KPNA2 promotes the progression of gastric cancer by regulating the alternative splicing of related genes. Sci Rep. 2024;14(1):17140.","journal-title":"Sci Rep"},{"issue":"1","key":"16456_CR15","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1186\/s12885-018-4261-5","volume":"18","author":"EM Vuorinen","year":"2018","unstructured":"Vuorinen EM, Rajala NK, Ihalainen TO, Kallioniemi A. Depletion of nuclear import protein karyopherin alpha 7 (KPNA7) induces mitotic defects and deformation of nuclei in cancer cells. BMC Cancer. 2018;18(1):325.","journal-title":"BMC Cancer"},{"issue":"21","key":"16456_CR16","doi-asserted-by":"publisher","first-page":"3413","DOI":"10.1042\/BCJ20190717","volume":"476","author":"LT Oostdyk","year":"2019","unstructured":"Oostdyk LT, McConnell MJ, Paschal BM. Characterization of the Importin-\u03b2 binding domain in nuclear import receptor KPNA7. Biochem J. 2019;476(21):3413\u201334.","journal-title":"Biochem J"},{"issue":"1","key":"16456_CR17","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.yexcr.2013.11.014","volume":"322","author":"E Laurila","year":"2014","unstructured":"Laurila E, Vuorinen E, Savinainen K, Rauhala H, Kallioniemi A. KPNA7, a nuclear transport receptor, promotes malignant properties of pancreatic cancer cells in vitro. Exp Cell Res. 2014;322(1):159\u201367.","journal-title":"Exp Cell Res"},{"issue":"2","key":"16456_CR18","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1016\/j.cell.2018.03.059","volume":"173","author":"A Blum","year":"2018","unstructured":"Blum A, Wang P, Zenklusen JC. SnapShot: TCGA-Analyzed Tumors. Cell. 2018;173(2):530.","journal-title":"Cell"},{"issue":"21","key":"16456_CR19","doi-asserted-by":"publisher","first-page":"e108","DOI":"10.1158\/0008-5472.CAN-17-0307","volume":"77","author":"T Li","year":"2017","unstructured":"Li T, Fan J, Wang B, Traugh N, Chen Q, Liu JS, Li B, Liu XS. TIMER: A Web Server for Comprehensive Analysis of Tumor-Infiltrating Immune Cells. Cancer Res. 2017;77(21):e108\u201310.","journal-title":"Cancer Res"},{"issue":"W1","key":"16456_CR20","doi-asserted-by":"publisher","first-page":"W98","DOI":"10.1093\/nar\/gkx247","volume":"45","author":"Z Tang","year":"2017","unstructured":"Tang Z, Li C, Kang B, Gao G, Li C, Zhang Z. GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res. 2017;45(W1):W98\u2013102.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"16456_CR21","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/s41435-024-00252-z","volume":"25","author":"Y Yao","year":"2024","unstructured":"Yao Y, Yang K, Wang Q, Zhu Z, Li S, Li B, Feng B, Tang C. Prediction of CAF-related genes in immunotherapy and drug sensitivity in hepatocellular carcinoma: a multi-database analysis. Genes Immun. 2024;25(1):55\u201365.","journal-title":"Genes Immun"},{"issue":"4","key":"16456_CR22","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1016\/j.immuni.2018.03.023","volume":"48","author":"V Thorsson","year":"2018","unstructured":"Thorsson V, Gibbs DL, Brown SD, Wolf D, Bortone DS, Ou Yang TH, Porta-Pardo E, Gao GF, Plaisier CL, Eddy JA, et al. The Immune Landscape of Cancer. Immunity. 2018;48(4):812\u2013e830814.","journal-title":"Immunity"},{"key":"16456_CR23","doi-asserted-by":"crossref","unstructured":"Bonneville R, Krook MA, Kautto EA, Miya J, Wing MR, Chen HZ, Reeser JW, Yu L, Roychowdhury S. Landscape of Microsatellite Instability Across 39 Cancer Types. JCO Precis Oncol. 2017;2017:PO.17.00073.","DOI":"10.1200\/PO.17.00073"},{"issue":"Database issue","key":"16456_CR24","first-page":"D955","volume":"41","author":"W Yang","year":"2013","unstructured":"Yang W, Soares J, Greninger P, Edelman EJ, Lightfoot H, Forbes S, Bindal N, Beare D, Smith JA, Thompson IR, et al. Genomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells. Nucleic Acids Res. 2013;41(Database issue):D955\u2013961.","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"16456_CR25","doi-asserted-by":"publisher","first-page":"D1373","DOI":"10.1093\/nar\/gkac956","volume":"51","author":"S Kim","year":"2023","unstructured":"Kim S, Chen J, Cheng T, Gindulyte A, He J, He S, Li Q, Shoemaker BA, Thiessen PA, Yu B, et al. PubChem 2023 update. Nucleic Acids Res. 2023;51(D1):D1373\u201380.","journal-title":"Nucleic Acids Res"},{"issue":"W1","key":"16456_CR26","doi-asserted-by":"publisher","first-page":"W60","DOI":"10.1093\/nar\/gky311","volume":"46","author":"M Franz","year":"2018","unstructured":"Franz M, Rodriguez H, Lopes C, Zuberi K, Montojo J, Bader GD, Morris Q. GeneMANIA update 2018. Nucleic Acids Res. 2018;46(W1):W60\u20134.","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"16456_CR27","doi-asserted-by":"publisher","first-page":"D638","DOI":"10.1093\/nar\/gkac1000","volume":"51","author":"D Szklarczyk","year":"2023","unstructured":"Szklarczyk D, Kirsch R, Koutrouli M, Nastou K, Mehryary F, Hachilif R, Gable AL, Fang T, Doncheva NT, Pyysalo S, et al. The STRING database in 2023: protein-protein association networks and functional enrichment analyses for any sequenced genome of interest. Nucleic Acids Res. 2023;51(D1):D638\u201346.","journal-title":"Nucleic Acids Res"},{"issue":"6","key":"16456_CR28","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","volume":"1","author":"A Liberzon","year":"2015","unstructured":"Liberzon A, Birger C, Thorvaldsd\u00f3ttir H, Ghandi M, Mesirov JP, Tamayo P. The Molecular Signatures Database (MSigDB) hallmark gene set collection. Cell Syst. 2015;1(6):417\u201325.","journal-title":"Cell Syst"},{"issue":"2","key":"16456_CR29","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.ccell.2020.10.001","volume":"39","author":"DL Jardim","year":"2021","unstructured":"Jardim DL, Goodman A, de Melo Gagliato D, Kurzrock R. The Challenges of Tumor Mutational Burden as an Immunotherapy Biomarker. Cancer Cell. 2021;39(2):154\u201373.","journal-title":"Cancer Cell"},{"issue":"1","key":"16456_CR30","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s13045-019-0738-1","volume":"12","author":"P Zhao","year":"2019","unstructured":"Zhao P, Li L, Jiang X, Li Q. Mismatch repair deficiency\/microsatellite instability-high as a predictor for anti-PD-1\/PD-L1 immunotherapy efficacy. J Hematol Oncol. 2019;12(1):54.","journal-title":"J Hematol Oncol"},{"issue":"1","key":"16456_CR31","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1038\/s41392-023-01649-4","volume":"8","author":"Y Yang","year":"2023","unstructured":"Yang Y, Guo L, Chen L, Gong B, Jia D, Sun Q. Nuclear transport proteins: structure, function, and disease relevance. Signal Transduct Target therapy. 2023;8(1):425.","journal-title":"Signal Transduct Target therapy"},{"key":"16456_CR32","doi-asserted-by":"publisher","first-page":"108208","DOI":"10.1016\/j.phrs.2026.108208","volume":"228","author":"H Ying","year":"2026","unstructured":"Ying H, Ran L, Huang Y, Yang K, Li X. Beyond the membrane: The emerging landscape of nuclear PD-L1. Pharmacol Res. 2026;228:108208.","journal-title":"Pharmacol Res"},{"key":"16456_CR33","doi-asserted-by":"publisher","first-page":"1621812","DOI":"10.3389\/fimmu.2025.1621812","volume":"16","author":"KJ Racacho","year":"2025","unstructured":"Racacho KJ, Shiau YP, Villa R, Mahri S, Tang M, Lin TY, Li Y. The tumor immune microenvironment: implications for cancer immunotherapy, treatment strategies, and monitoring approaches. Front Immunol. 2025;16:1621812.","journal-title":"Front Immunol"},{"key":"16456_CR34","doi-asserted-by":"publisher","first-page":"1517959","DOI":"10.3389\/fimmu.2025.1517959","volume":"16","author":"J Yu","year":"2025","unstructured":"Yu J, Fu L, Wu R, Che L, Liu G, Ran Q, Xia Z, Liang X, Zhao G. Immunocytes in the tumor microenvironment: recent updates and interconnections. Front Immunol. 2025;16:1517959.","journal-title":"Front Immunol"},{"issue":"9","key":"16456_CR35","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1016\/j.trecan.2025.04.016","volume":"11","author":"N Goto","year":"2025","unstructured":"Goto N, Agudo J, Yilmaz \u00d6H. Early immune evasion in colorectal cancer: interplay between stem cells and the tumor microenvironment. Trends cancer. 2025;11(9):850\u201361.","journal-title":"Trends cancer"},{"issue":"3","key":"16456_CR36","doi-asserted-by":"publisher","first-page":"e005923","DOI":"10.1136\/jitc-2022-005923","volume":"11","author":"MB Atkins","year":"2023","unstructured":"Atkins MB, Ascierto PA, Feltquate D, Gulley JL, Johnson DB, Khushalani NI, Sosman J, Yap TA, Kluger H, Sullivan RJ, et al. Society for Immunotherapy of Cancer (SITC) consensus definitions for resistance to combinations of immune checkpoint inhibitors with targeted therapies. J Immunother Cancer. 2023;11(3):e005923.","journal-title":"J Immunother Cancer"},{"issue":"1","key":"16456_CR37","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1186\/s12943-025-02305-x","volume":"24","author":"M Zhang","year":"2025","unstructured":"Zhang M, Liu C, Tu J, Tang M, Ashrafizadeh M, Nabavi N, Sethi G, Zhao P, Liu S. Advances in cancer immunotherapy: historical perspectives, current developments, and future directions. Mol Cancer. 2025;24(1):136.","journal-title":"Mol Cancer"},{"issue":"5","key":"16456_CR38","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/S1470-2045(16)30033-X","volume":"17","author":"K Park","year":"2016","unstructured":"Park K, Tan EH, O\u2019Byrne K, Zhang L, Boyer M, Mok T, Hirsh V, Yang JC, Lee KH, Lu S, et al. Afatinib versus gefitinib as first-line treatment of patients with EGFR mutation-positive non-small-cell lung cancer (LUX-Lung 7): a phase 2B, open-label, randomised controlled trial. Lancet Oncol. 2016;17(5):577\u201389.","journal-title":"Lancet Oncol"},{"key":"16456_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.mce.2017.05.033","volume":"451","author":"B Groner","year":"2017","unstructured":"Groner B, von Manstein V. Jak Stat signaling and cancer: Opportunities, benefits and side effects of targeted inhibition. Mol Cell Endocrinol. 2017;451:1\u201314.","journal-title":"Mol Cell Endocrinol"},{"issue":"1","key":"16456_CR40","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s13046-024-02949-5","volume":"43","author":"Y Hu","year":"2024","unstructured":"Hu Y, Dong Z, Liu K. Unraveling the complexity of STAT3 in cancer: molecular understanding and drug discovery. J experimental Clin cancer research: CR. 2024;43(1):23.","journal-title":"J experimental Clin cancer research: CR"},{"issue":"1","key":"16456_CR41","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1038\/s41420-025-02503-y","volume":"11","author":"DM Xu","year":"2025","unstructured":"Xu DM, Chen LX, Xue T, Zhuang XY, Wei LC, Han H, Mo M. Decoding the impact of MMP1\u2009+\u2009malignant subsets on tumor-immune interactions: insights from single-cell and spatial transcriptomics. Cell death discovery. 2025;11(1):244.","journal-title":"Cell death discovery"},{"issue":"1","key":"16456_CR42","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1186\/s12967-025-06596-y","volume":"23","author":"Q Wang","year":"2025","unstructured":"Wang Q, Feng W, Tan Y, Qiao J, Liu H, Liu Q, Wang H, Zhang Q, Tao J, Li Z, et al. Antiphospholipid antibodies inhibit the migration and invasion of trophoblast cells by suppressing the JNK\/C-Jun\/MMP1 signaling pathway. J translational Med. 2025;23(1):581.","journal-title":"J translational Med"},{"issue":"5","key":"16456_CR43","doi-asserted-by":"publisher","first-page":"101529","DOI":"10.1016\/j.gendis.2025.101529","volume":"12","author":"S Tian","year":"2025","unstructured":"Tian S, Chen X, Li J. Zinc finger transcription factor ZNF24 inhibits colorectal cancer growth and metastasis by suppressing MMP2 transcription. Genes Dis. 2025;12(5):101529.","journal-title":"Genes Dis"},{"issue":"1","key":"16456_CR44","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1038\/s41420-024-01962-z","volume":"10","author":"P Xing","year":"2024","unstructured":"Xing P, Liu H, Xiao W, Zhang G, Zhang C, Liao Z, Li T, Yang J. The fusion gene LRP1-SNRNP25 drives invasion and migration by activating the pJNK\/37LRP\/MMP2 signaling pathway in osteosarcoma. Cell death discovery. 2024;10(1):198.","journal-title":"Cell death discovery"},{"issue":"1","key":"16456_CR45","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1038\/s41420-025-02536-3","volume":"11","author":"Z Wang","year":"2025","unstructured":"Wang Z, Sun H, Zhu S, Wang F, Li Q, Zhou J. RGS3 acts as a tumor promoter by facilitating the regulation of the TGF-\u03b2 signaling pathway and promoting EMT in ovarian cancer. Cell death discovery. 2025;11(1):262.","journal-title":"Cell death discovery"},{"issue":"1","key":"16456_CR46","doi-asserted-by":"publisher","first-page":"101771","DOI":"10.1016\/j.gendis.2025.101771","volume":"13","author":"C Liu","year":"2026","unstructured":"Liu C, Wang S, Zhang X, Han Y, Tan M, Fan J, Du J, Fan Y, Zhao X. The biomechanical signature of tumor invasion. Genes Dis. 2026;13(1):101771.","journal-title":"Genes Dis"},{"issue":"1","key":"16456_CR47","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1186\/s12967-025-06526-y","volume":"23","author":"Z Hao","year":"2025","unstructured":"Hao Z, Zhang M, Du Y, Liu J, Zeng G, Li H, Peng X. Invadopodia in cancer metastasis: dynamics, regulation, and targeted therapies. J translational Med. 2025;23(1):548.","journal-title":"J translational Med"},{"issue":"1","key":"16456_CR48","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1186\/s12967-025-06328-2","volume":"23","author":"Y Li","year":"2025","unstructured":"Li Y, Wang H, Mao D, Che X, Chen Y, Liu Y. Understanding pre-metastatic niche formation: implications for colorectal cancer liver metastasis. J translational Med. 2025;23(1):340.","journal-title":"J translational Med"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-026-16456-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-16456-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-16456-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T15:01:42Z","timestamp":1792508502000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-026-16456-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,24]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["16456"],"URL":"https:\/\/doi.org\/10.1186\/s12885-026-16456-7","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,24]]},"assertion":[{"value":"20 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All animal experiments involved in this study were approved by the Ethics Committee of The First Hospital of Lanzhou University (LDYYLL2025-470).","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1262"}}